Skip to content
AwardedPOLGoods

SZP.281.20.2026 Dostawa produktów leczniczych do stosowania w ramach programów lekowych, chemioterapii oraz RDTL dla Instytutu „CZMP”

Published
Published 26 March 2026
Deadline
Closed 28 April 2026

Overview

The Instytut "Centrum Zdrowia Matki Polki" procured pharmaceutical products for use in drug programs, chemotherapy, and RDTL (reproductive and developmental toxicology programs). The contract was awarded on 24 June 2026 for PLN 81,847,368.09 to a consortium of 14 suppliers including Amgen, AstraZeneca, Baxter Polska, GSK Services, Janssen-Cilag Polska, Roche Polska, and others.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
26 March 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 81,847,368
Award date
24 June 2026
Contract period
— → 21 December 2001
Winners
  • Amgen sp. z o. o.
  • Asclepios. S. A.
  • AstraZeneca Kft.
  • Baxter Polska sp. z o. o.
  • CSL Behring Sp. z o. o.
  • Farmacol-Logistyka sp. z o. o.
  • GSK Services Sp. z o. o.
  • Janssen-Cilag Polska sp. z o. o.
  • Komtur Polska sp. z o. o.
  • LEK S. A.
  • Roche Polska sp. z o. o.
  • Salus International sp. z o. o.
  • Takeda Pharma sp. z o. o.
  • Urtica sp. z o. o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 July 2026

  2. Contract Notice

    26 March 2026

Contracting authority

  • Instytut „Centrum Zdrowia Matki Polki”

    Procuring entity

    Łódź, POL

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: SZP.281.20.2026 Dostawa produktów leczniczych do stosowania w ramach programów lekowych, chemioterapii oraz RDTL dla Instytutu „CZMP” — won by Amgen sp. z o. o. +13 — Skim